Regulatory Workflows and Interactions - pharma
0.1.0 - ci-build
Regulatory Workflows and Interactions - pharma
0.1.0 - ci-build
Regulatory Workflows and Interactions - pharma, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/APIX---API-Exchange-for-Medicinal-Products/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
Once a regulator or company implements RWI-pharma, the same connection pattern supports every regulatory interaction for human biopharmaceutical products. The three use cases below show what that makes possible — select one to explore it in detail.
One pattern for post-approval changes, ICSRs, label negotiation, and health authority questions.
Follow every interaction step by step, like tracking a FedEx or Amazon package.
Route questions and responses to the right people the moment they arrive.
IG © 2025+ HL7 International / Biomedical Research and Regulation.
Package hl7.fhir.uv.apix#0.1.0 based on FHIR 5.0.0.
Generated
2026-10-19
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change